No Picture
News

As Takeda absorbs Shire’s R&D ops, the focus is on replacing a centralized command model with a ‘light touch’ in a restructured global organization

At Takeda, one of the top priorities in the R&D group since the $62 billion acquisition of Shire closed at the beginning of the year has been centered on creating a shared culture ? and that calls for some group activities.?
Six weeks after the dea… […]

No Picture
News

Aptose To Release Second Quarter Ended June 30, 2019 Financial Results and Hold Conference Call on August 6, 2019

SAN DIEGO and TORONTO, July 23, 2019 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated processes and signaling pathways of cancer… […]

No Picture
News

Obalon Schedules Second Quarter 2019 Financial Results Conference Call for July 24, 2019 at 8:30 a.m. Eastern Time

SAN DIEGO, July 22, 2019 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of ob… […]

No Picture
News

GenMark Diagnostics Schedules Second Quarter 2019 Financial Results Conference Call for August 5, 2019

CARLSBAD, Calif., July 22, 2019 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close on?Monday, August 5, 2019. Management will hold a conference … […]

No Picture
News

Abzena Announces Successful Technical Transfer of Synaffix GlycoConnect? Antibody Drug Conjugate (ADC) Technology to Enable Use in Client Projects

SAN DIEGO–(BUSINESS WIRE)–Abzena, the global partner research organization, announced it has successfully completed a technology transfer and scalability evaluation using the Synaffix technologies of GlycoConnect? (antibody conjugation) and HydraSpac… […]